The safety of gliptins: updated data in 2018
Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, Loomba R, Harrison SA, Balabanska R, Mateva L, Lanthier N, Alkhouri N, Moreno C, Schattenberg JM, Stefanova-Petrova D, Vonghia L, Rouzier R, Guillaume M, Hodge A, Romero-Gmez M, Huot-Marchand P, Baudin M, Richard M-P, Abitbol J-L, Broqua P, Junien J-L, Abdelmalek MF
Cost: $1,112.16 per month Zepbound is FDA-approved for chronic weight management in adults with obesity or adults with overweight and a weight-related health condition (e.g
Medication selection should consider the patient's comorbidity profile, previous medication responses, potential drug interactions, and individual preferences